Výsledky vyhledávání - "Versteegh, Richard T."

Cell cycle arrest and clonogenic tumor cell kill by divergent chemotherapeutic drugs

Autor: Mastbergen, Simon C., Duivenvoorden, Ilse, Versteegh, Richard T., Geldof, Albert A.

Publikováno v: Mastbergen, S C, Duivenvoorden, I, Versteegh, R T & Geldof, A A 2000, ' Cell cycle arrest and clonogenic tumor cell kill by divergent chemotherapeutic drugs ', Anticancer Research, vol. 20, no. 3 A, pp. 1833-1838 .
Anticancer Research, 20(3 A), 1833-1838. International Institute of Anticancer Research

Background: Regulators of cell cycle phase transitions could be important targets for cancer treatment using cytostatic chemotherapy. Therefore, the extent of cell cycle arrest induced by different cytostatic agents has to be correlated with ultimate

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::27310d3f43d6a04d7af61c280f6c17d4
https://research.vumc.nl/en/publications/bbc96692-05c0-43ae-8e77-c08daa0783a9

Zobrazit plný text záznamu

Combination 186Re-HEDP and cisplatin supra-additive treatment effects in prostate cancer cells

Autor: Geldof, Albert A., De Rooij, Laurens, Versteegh, Richard T., Newling, Donald W.W., Teule, Gerrit J.J.

Publikováno v: Geldof, A A, De Rooij, L, Versteegh, R T, Newling, D W W & Teule, G J J 1999, ' Combination 186 Re-HEDP and cisplatin supra-additive treatment effects in prostate cancer cells ', Journal of Nuclear Medicine, vol. 40, no. 4, pp. 667-671 .
Journal of Nuclear Medicine, 40(4), 667-671. Society of Nuclear Medicine Inc.

Radionuclide therapy has proven to be an efficacious palliative treatment for metastatic prostate cancer. Its potential therapeutic possibilities may be substantially increased by combining it with effective radiosensitizing drugs. Methods: This stud

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::55cf7d120dd1a8254c097541dd1f7289
https://research.vumc.nl/en/publications/83cb5190-f80b-4883-97bb-b9062ff49eeb

Zobrazit plný text záznamu